Skip to main content

and
  1. Article

    Open Access

    Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa

    Although direct-acting antivirals (DAA) have become standard care for patients with chronic hepatitis C worldwide, there is no evidence for their value for money in sub-Saharan Africa. We assessed the cost-eff...

    Sylvie Boyer, Maël Baudoin, Marie Libérée Nishimwe in BMC Health Services Research (2022)